Select Medical Holdings Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Select Medical Holdings stock have an average target of $16.5, which predicts a -0.36% decrease from the current stock price of 16.56.

Price Target: $16.5 (-0.36%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$16.5	$16.5	$16.5	$16.5
Change	-0.36%	-0.36%	-0.36%	-0.36%

* Price targets were last updated on May 12, 2026.

Analyst Ratings

The average analyst rating for Select Medical Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	1	1	0
Buy	1	1	1	0	0	0
Hold	1	1	1	4	4	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ann Hynes Mizuho Securities	Mizuho Securities	Hold Downgrades $17 → $17	Hold	Downgrades	$17 → $17	-0.36%	May 12, 2026
Ben Hendrix RBC Capital	RBC Capital	Hold Maintains $17	Hold	Maintains	$17	-0.36%	May 6, 2026
Bill Sutherland Benchmark Co.	Benchmark Co.	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Mar 4, 2026
Justin Bowers Deutsche Bank	Deutsche Bank	Hold Downgrades $16 → $17	Hold	Downgrades	$16 → $17	-0.36%	Mar 4, 2026

Financial Forecast

Revenue This Year

5.70B

from 5.45B

4.58%

from 5.45B

Revenue Next Year

5.96B

from 5.70B

4.48%

from 5.70B

EPS This Year

1.23

from 1.16

5.66%

from 1.16

EPS Next Year

1.36

from 1.23

11.07%

from 1.23

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.20B	4.61B	4.83B	5.19B	5.45B	5.70B
Revenue Growth	12.16%	-25.71%	4.70%	7.48%	5.12%	4.58%
Gross Profit	1.26B	655.59M	836.47M	915.54M	924.80M	659.71M
Gross Margin	20.36%	14.22%	17.33%	17.65%	16.96%	11.57%
Operating Income	570.07M	116.30M	267.24M	268.32M	336.17M	365.86M
Net Income	402.23M	158.99M	243.49M	214.04M	146.22M	152.55M
EPS	-	-	-	-	1.16	1.23
EPS Growth	-	-	-	-	23.40%	5.66%
Forward PE	10.87	12.92	10.93	13.19	12.27	13.51
Dividend / Share	0.50	0.50	0.50	0.44	0.25	0.25
Dividend Growth	-	-	-	-12.50%	-42.86%	-
Free Cash Flow	57.88M	-206.27M	110.93M	72.72M	31.78M	272.20M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	5.7B
Avg	5.7B
Low	5.7B

Revenue Growth

Revenue Growth	2026	2027	2028
High	5.0%
Avg	4.6%
Low	3.9%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	1.23
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	5.7%
Low	-